Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

HUJ is the latest site for Evotec's Bridge drug discovery model, which supports pre-spinout academic research to advance promising drug candidates.

The Celgene and GV-backed cancer and atopic dermatitis drug developer is now targeting $75m in an initial public offering it postponed in August.

Purdue’s Double Down Experiment accelerator will assist nine growth-stage businesses linked to the university with resources as they look to realise their expansion ambitions.

Shine Medical has increased its lifetime funding to around $283m as it prepares to launch medical isotope production plants leveraging fusion-based neutron generators invented at UW-Madison.

Ally Financial venture capital unit has contributed to health savings account provider Lively’s latest round to take its total funding to approximately $42m.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

3SBio and Alexandria Venture Investments have both contributed to a $50m round raised by Verseau, which is developing immunotherapies based on MIT research.

Strategic partner 3SBio and Alexandria Venture Investments have both contributed to a $50m round raised by Verseau that was disclosed as it emerged from stealth.

The care provider is supplying $50m for its Translational Innovation Fund while $30m is reserved for its Artificial Intelligence and Digital Translation Fund.